BioMark Announces Partnership With The Metabolomics Innovation Centre - Biomark Diagnostics

News

March 27, 2015

BioMark Announces Partnership With The Metabolomics Innovation Centre

BioMark Diagnostics Inc.

BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.

BIOMARK_ANNOUNCES_PARTNERSHIP_WITH_THE_METABOLOMICS_INNOVATION_CENTRE (PDF)

———————————————

Share this post:

Categories

Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.

CSE: BUX
OTC: BMKDF
FSE: 20B

More Information

Investors

Related articles ...

biomark diagnostics 3rd annual congress of international society of liquid biopsy

News

BioMark Diagnostics to Present at 3rd Annual Congress of the International Society of Liquid Biopsy

Liquid Biopsy Company “BioMark Diagnostics” to Present at the 3rd Annual Congress of the International

October 18, 2021

biomark progress report

Articles and Information

Biomark Diagnostics Monthly Progress Report October 4 2021

FORM 7 MONTHLY PROGRESS REPORT Name of listed Issuer: BioMark Diagnostics Inc. (the “issuer”). Trading

October 3, 2021

biomark diagnostics qtrap 6500 mass spectrometer

Articles and Information

BioMark’s Quebec Laboratory Begins To Take Shape

BioMark Diagnostics is pleased to announce that the installation of its Quebec laboratory is now

September 22, 2021

News

Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patient Receiving Immunotherapy

Vancouver, British Columbia – (June 29th, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:

June 29, 2021

News

BIOMARK RECEIVES $825K GRANT TO DEVELOP ITS LIQUID BIOPSY ASSAY FOR LUNG CANCER SCREENING

Vancouver, British Columbia – (June 1st, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE:

June 1, 2021

© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.